PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1916511
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1916511
DNA Sequencing Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
Growth Factors of DNA sequencing Market
The global DNA sequencing market is a fundamental pillar of modern genomics, enabling precise identification of nucleotide sequences for disease diagnosis, drug development, personalized medicine, forensic science, and evolutionary research. DNA sequencing technologies have transitioned from first-generation Sanger sequencing to high-throughput Next-Generation Sequencing (NGS) and advanced Third-Generation Sequencing (TGS) platforms, offering rapid processing, long-read capabilities, and enhanced accuracy. These advancements have expanded sequencing applications across clinical diagnostics, oncology, rare disease detection, and population-scale genomics initiatives.
DNA Sequencing Market Size and Market Value
As per the market report, the global DNA sequencing market size was valued at USD 12.31 billion in 2025. The market is projected to grow to USD 13.36 billion in 2026, supported by rising adoption of sequencing technologies in diagnostics and research laboratories. Over the forecast period, the market is expected to reach a market value of USD 27.25 billion by 2034, reflecting rapid integration of sequencing into routine clinical workflows and pharmaceutical research pipelines. The market is projected to expand at a CAGR of 9.32% from 2026 to 2034, driven by technological innovation, regulatory approvals, and expanding clinical utility of genomic data.
Market Drivers Supporting Growth
The growing adoption of Whole Genome Sequencing (WGS) in clinical diagnostics is a major growth driver. WGS enables comprehensive detection of genetic variations that traditional methods often fail to identify, supporting early diagnosis and targeted therapy selection. Rising prevalence of genetic disorders and cancer is increasing reliance on genomic profiling for treatment planning.
Expanding use of sequencing data in drug discovery and biomarker identification is further driving demand. Pharmaceutical companies increasingly rely on genomic datasets for patient stratification, clinical trial optimization, and identification of therapeutic targets. Public and private investments in genomics infrastructure, national genome mapping programs, and regulatory support for NGS-based diagnostics are accelerating clinical integration.
Market Restraints and Challenges
A major restraint is the global shortage of skilled professionals in genomics and bioinformatics. Interpreting sequencing data requires specialized computational expertise, limiting adoption in resource-constrained healthcare systems. Technical challenges such as sequencing errors, false positives, and limitations in detecting repetitive genomic regions also affect diagnostic reliability.
Data security and privacy concerns remain critical, as genomic information is highly sensitive. Lack of standardized global regulatory frameworks for genomic data handling and cross-border research collaborations further complicates market expansion, especially in emerging economies.
Market Trends and Technological Advancements
Third-Generation Sequencing platforms are gaining strong momentum due to their ability to generate long reads, enabling accurate detection of structural variants and epigenetic modifications. Nanopore and Single-Molecule Real-Time sequencing are increasingly adopted in cancer research, rare disease diagnostics, and microbiome analysis.
Integration of artificial intelligence and machine learning in data interpretation is becoming a major trend, helping laboratories analyze massive datasets more efficiently. Cloud-based bioinformatics platforms are also improving data storage, accessibility, and collaboration across research institutions.
Liquid biopsy sequencing is gaining traction for non-invasive cancer monitoring by detecting circulating tumor DNA, improving early detection and treatment monitoring.
Segmentation Analysis by Products and Services
By products and services, the market is divided into products and software & services. The products segment dominated the market with a 63.29% share in 2026, driven by high demand for sequencing instruments, flow cells, and reagent kits. Consumables are expected to grow rapidly due to repeat purchase cycles associated with sequencing workflows.
The software and services segment is witnessing strong growth due to increasing outsourcing of sequencing services and demand for bioinformatics solutions, particularly in clinical and pharmaceutical research settings.
Segmentation by Technique and Type
By technique, Next-Generation Sequencing held the largest market share and is projected to capture 85.99% share in 2026, driven by its cost efficiency, scalability, and compatibility with multiple clinical applications. Third-Generation Sequencing is growing at the fastest pace due to long-read sequencing advantages, while Sanger sequencing remains relevant for validation and small-scale research.
By type, targeted sequencing dominated in 2024 due to its widespread use in oncology diagnostics. Whole genome and whole exome sequencing is expanding rapidly, with an estimated 45.98% market share in 2026, driven by rare disease diagnostics and population genomics studies. Epigenomics is growing rapidly due to rising cancer research applications.
Segmentation by Application and End User
By application, diagnostics leads the market, supported by growing cancer screening programs and genetic disorder testing. Drug discovery and development represents the second-largest segment, driven by genomics-guided clinical trials and biomarker research.
By end user, diagnostic centers dominate due to increasing adoption of NGS in oncology and prenatal screening. Academic and research institutes remain strong contributors through large-scale genome projects, while biotechnology and pharmaceutical companies continue expanding internal sequencing capabilities.
Regional Outlook
North America dominated the DNA sequencing market with USD 5.74 billion in 2025 and USD 6.21 billion in 2026, supported by advanced research infrastructure, strong reimbursement systems, and large multi-omics programs. The U.S. remains the largest national market due to extensive clinical sequencing adoption and biotechnology investments.
Europe follows with strong government funding, national genome initiatives, and rising cancer prevalence. Asia Pacific is the fastest-growing region due to expanding healthcare investments, government genomics programs, and domestic manufacturing partnerships in China, Japan, and India. Latin America and the Middle East & Africa are witnessing gradual growth supported by expanding diagnostic infrastructure.
Competitive Landscape
Major companies operating in the DNA sequencing market include Illumina, Thermo Fisher Scientific, Oxford Nanopore Technologies, PacBio, QIAGEN, PerkinElmer, Azenta, and BGI Genomics. These players focus on new platform launches, bioinformatics integration, geographic expansion, and strategic collaborations with healthcare and research institutions. Investments in long-read sequencing, automation, and AI-driven analytics remain central to competitive differentiation.
Conclusion
The DNA sequencing market is experiencing strong and sustained growth, driven by rapid technological advancements, expanding clinical applications, and increasing integration of genomics into routine healthcare and pharmaceutical research. With the market valued at USD 12.31 billion in 2025, projected to reach USD 13.36 billion in 2026, and expected to expand to USD 27.25 billion by 2034, the industry reflects robust long-term potential. Rising adoption of whole genome and targeted sequencing in oncology, rare disease diagnosis, and personalized medicine, along with growing use in drug discovery and biomarker development, is strengthening market demand. Although challenges such as shortage of skilled professionals, data interpretation complexity, and privacy concerns persist, continuous innovation in next-generation and third-generation sequencing platforms, integration of AI-driven bioinformatics, and expanding government-supported genomics initiatives are expected to further accelerate market adoption across developed and emerging regions.
Segmentation By Products & Services
- Products
- Equipment
- Consumables
- Software & Services
By Technique
- Sanger Sequencing
- Next-generation Sequencing
- Third-generation Sequencing
By Type
- Whole Genome / Exome Sequencing
- Epigenomics
- Targeted Sequencing
- Metagenomics
- Others
By Application
- Drug Discovery & Development
- Diagnostics
- Personalized Medicine
- Others
By End-user
- Biotechnology & Pharmaceutical Companies
- Diagnostic Centers
- Academic & Research Institutes
- Others
By Region
- North America (By Products & Services, Technique, Type, Application, End-user, and Country)
- U.S.
- Canada
- Europe (By Products & Services, Technique, Type, Application, End-user, and Country/ Sub-region)
- U.K.
- Germany
- France
- Spain
- Italy
- Scandinavia
- Rest of Europe
- Asia Pacific (By Products & Services, Technique, Type, Application, End-user, and Country/ Sub-region)
- Japan
- China
- India
- Australia
- Southeast Asia
- Rest of Asia Pacific
- Latin America (By Products & Services, Technique, Type, Application, End-user, and Country/ Sub-region)
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa (By Products & Services, Technique, Type, Application, End-user, and Country/ Sub-region)
- GCC
- South Africa
- Rest of the Middle East & Africa
Table of Content
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 3.4. Market Trends
4. Key Insights
- 4.1. Prevalence of Key Diseases, By Key Countries, 2025
- 4.2. Technological Advancement in DNA Sequencing
- 4.3. Overview: Emerging Trends in the DNA Sequencing
- 4.4. New Product Launches/ Approvals, By Key Players
- 4.5. Key Industry Developments- Mergers, Partnerships, Acquisitions, etc.
- 4.6. Impact of COVID-19 on the Market
5. Global DNA Sequencing Market Analysis, Insights and Forecast, 2021-2034
- 5.1. Market Analysis, Insights and Forecast - By Products & Services
- 5.1.1. Products
- 5.1.1.1. Equipment
- 5.1.1.2. Consumables
- 5.1.2. Software & Services
- 5.1.1. Products
- 5.2. Market Analysis, Insights and Forecast - By Technique
- 5.2.1. Sanger Sequencing
- 5.2.2. Next-generation Sequencing
- 5.2.3. Third-generation Sequencing
- 5.3. Market Analysis, Insights and Forecast - By Type
- 5.3.1. Whole Genome / Exome Sequencing
- 5.3.2. Epigenetics
- 5.3.3. Targeted Sequencing
- 5.3.4. Metagenomics
- 5.3.5. Others
- 5.4. Market Analysis, Insights and Forecast - By Application
- 5.4.1. Drug Discovery & Development
- 5.4.2. Diagnostics
- 5.4.3. Personalized Medicine
- 5.4.4. Others
- 5.5. Market Analysis, Insights and Forecast - By End-user
- 5.5.1. Biotechnology & Pharmaceutical Companies
- 5.5.2. Diagnostics Centers
- 5.5.3. Academic & Research Institutes
- 5.5.4. Others
- 5.6. Market Analysis, Insights and Forecast - By Region
- 5.6.1. North America
- 5.6.2. Europe
- 5.6.3. Asia Pacific
- 5.6.4. Latin America
- 5.6.5. Middle East & Africa
6. North America DNA Sequencing Market Analysis, Insights and Forecast, 2021-2034
- 6.1. Market Analysis, Insights and Forecast - By Products & Services
- 6.1.1. Products
- 6.1.1.1. Equipment
- 6.1.1.2. Consumables
- 6.1.2. Software & Services
- 6.1.1. Products
- 6.2. Market Analysis, Insights and Forecast - By Technique
- 6.2.1. Sanger Sequencing
- 6.2.2. Next-generation Sequencing
- 6.2.3. Third-generation Sequencing
- 6.3. Market Analysis, Insights and Forecast - By Type
- 6.3.1. Whole Genome / Exome Sequencing
- 6.3.2. Epigenetics
- 6.3.3. Targeted Sequencing
- 6.3.4. Metagenomics
- 6.3.5. Others
- 6.4. Market Analysis, Insights and Forecast - By Application
- 6.4.1. Drug Discovery & Development
- 6.4.2. Diagnostics
- 6.4.3. Personalized Medicine
- 6.4.4. Others
- 6.5. Market Analysis, Insights and Forecast - By End-user
- 6.5.1. Biotechnology & Pharmaceutical Companies
- 6.5.2. Diagnostics Centers
- 6.5.3. Academic & Research Institutes
- 6.5.4. Others
- 6.6. Market Analysis, Insights and Forecast - By Country
- 6.6.1. U.S.
- 6.6.2. Canada
7. Europe DNA Sequencing Market Analysis, Insights and Forecast, 2021-2034
- 7.1. Market Analysis, Insights and Forecast - By Products & Services
- 7.1.1. Products
- 7.1.1.1. Equipment
- 7.1.1.2. Consumables
- 7.1.2. Software & Services
- 7.1.1. Products
- 7.2. Market Analysis, Insights and Forecast - By Technique
- 7.2.1. Sanger Sequencing
- 7.2.2. Next-generation Sequencing
- 7.2.3. Third-generation Sequencing
- 7.3. Market Analysis, Insights and Forecast - By Type
- 7.3.1. Whole Genome / Exome Sequencing
- 7.3.2. Epigenetics
- 7.3.3. Targeted Sequencing
- 7.3.4. Metagenomics
- 7.3.5. Others
- 7.4. Market Analysis, Insights and Forecast - By Application
- 7.4.1. Drug Discovery & Development
- 7.4.2. Diagnostics
- 7.4.3. Personalized Medicine
- 7.4.4. Others
- 7.5. Market Analysis, Insights and Forecast - By End-user
- 7.5.1. Biotechnology & Pharmaceutical Companies
- 7.5.2. Diagnostics Centers
- 7.5.3. Academic & Research Institutes
- 7.5.4. Others
- 7.6. Market Analysis, Insights and Forecast - By Country/ Sub-region
- 7.6.1. Germany
- 7.6.2. U.K.
- 7.6.3. France
- 7.6.4. Italy
- 7.6.5. Spain
- 7.6.6. Scandinavia
- 7.6.7. Rest of Europe
8. Asia Pacific DNA Sequencing Market Analysis, Insights and Forecast, 2021-2034
- 8.1. Market Analysis, Insights and Forecast - By Products & Services
- 8.1.1. Products
- 8.1.1.1. Equipment
- 8.1.1.2. Consumables
- 8.1.2. Software & Services
- 8.1.1. Products
- 8.2. Market Analysis, Insights and Forecast - By Technique
- 8.2.1. Sanger Sequencing
- 8.2.2. Next-generation Sequencing
- 8.2.3. Third-generation Sequencing
- 8.3. Market Analysis, Insights and Forecast - By Type
- 8.3.1. Whole Genome / Exome Sequencing
- 8.3.2. Epigenetics
- 8.3.3. Targeted Sequencing
- 8.3.4. Metagenomics
- 8.3.5. Others
- 8.4. Market Analysis, Insights and Forecast - By Application
- 8.4.1. Drug Discovery & Development
- 8.4.2. Diagnostics
- 8.4.3. Personalized Medicine
- 8.4.4. Others
- 8.5. Market Analysis, Insights and Forecast - By End-user
- 8.5.1. Biotechnology & Pharmaceutical Companies
- 8.5.2. Diagnostics Centers
- 8.5.3. Academic & Research Institutes
- 8.5.4. Others
- 8.6. Market Analysis, Insights and Forecast - By Country/ Sub-region
- 8.6.1. China
- 8.6.2. India
- 8.6.3. Japan
- 8.6.4. South Korea
- 8.6.5. Southeast Asia
- 8.6.6. Rest of Asia Pacific
9. Latin America DNA Sequencing Market Analysis, Insights and Forecast, 2021-2034
- 9.1. Market Analysis, Insights and Forecast - By Products & Services
- 9.1.1. Products
- 9.1.1.1. Equipment
- 9.1.1.2. Consumables
- 9.1.2. Software & Services
- 9.1.1. Products
- 9.2. Market Analysis, Insights and Forecast - By Technique
- 9.2.1. Sanger Sequencing
- 9.2.2. Next-generation Sequencing
- 9.2.3. Third-generation Sequencing
- 9.3. Market Analysis, Insights and Forecast - By Type
- 9.3.1. Whole Genome / Exome Sequencing
- 9.3.2. Epigenetics
- 9.3.3. Targeted Sequencing
- 9.3.4. Metagenomics
- 9.3.5. Others
- 9.4. Market Analysis, Insights and Forecast - By Application
- 9.4.1. Drug Discovery & Development
- 9.4.2. Diagnostics
- 9.4.3. Personalized Medicine
- 9.4.4. Others
- 9.5. Market Analysis, Insights and Forecast - By End-user
- 9.5.1. Biotechnology & Pharmaceutical Companies
- 9.5.2. Diagnostics Centers
- 9.5.3. Academic & Research Institutes
- 9.5.4. Others
- 9.6. Market Analysis, Insights and Forecast - By Country/ Sub-region
- 9.6.1. Brazil
- 9.6.2. Mexico
- 9.6.3. Rest of Latin America
10. Middle East & Africa DNA Sequencing Market Analysis, Insights and Forecast, 2021-2034
- 10.1. Market Analysis, Insights and Forecast - By Products & Services
- 10.1.1. Products
- 10.1.1.1. Equipment
- 10.1.1.2. Consumables
- 10.1.2. Software & Services
- 10.1.1. Products
- 10.2. Market Analysis, Insights and Forecast - By Technique
- 10.2.1. Sanger Sequencing
- 10.2.2. Next-generation Sequencing
- 10.2.3. Third-generation Sequencing
- 10.3. Market Analysis, Insights and Forecast - By Type
- 10.3.1. Whole Genome / Exome Sequencing
- 10.3.2. Epigenetics
- 10.3.3. Targeted Sequencing
- 10.3.4. Metagenomics
- 10.3.5. Others
- 10.4. Market Analysis, Insights and Forecast - By Application
- 10.4.1. Drug Discovery & Development
- 10.4.2. Diagnostics
- 10.4.3. Personalized Medicine
- 10.4.4. Others
- 10.5. Market Analysis, Insights and Forecast - By End-user
- 10.5.1. Biotechnology & Pharmaceutical Companies
- 10.5.2. Diagnostics Centers
- 10.5.3. Academic & Research Institutes
- 10.5.4. Others
- 10.6. Market Analysis, Insights and Forecast - By Country/ Sub-region
- 10.6.1. GCC
- 10.6.2. South Africa
- 10.6.3. Rest of Middle East & Africa
11. Competitive Analysis
- 11.1. Global Market Share Analysis (2025)
- 11.2. Company Profiles
- 11.2.1. Illumina, Inc.
- 11.2.1.1. Overview
- 11.2.1.2. Products & services
- 11.2.1.3. SWOT Analysis
- 11.2.1.4. Recent Developments
- 11.2.1.5. Strategies
- 11.2.1.6. Financials (Based on Availability)
- 11.2.2. Thermo Fisher Scientific Inc.
- 11.2.2.1. Overview
- 11.2.2.2. Products & services
- 11.2.2.3. SWOT Analysis
- 11.2.2.4. Recent Developments
- 11.2.2.5. Strategies
- 11.2.2.6. Financials (Based on Availability)
- 11.2.3. Oxford Nanopore Technologies plc.
- 11.2.3.1. Overview
- 11.2.3.2. Products & services
- 11.2.3.3. SWOT Analysis
- 11.2.3.4. Recent Developments
- 11.2.3.5. Strategies
- 11.2.3.6. Financials (Based on Availability)
- 11.2.4. PacBio
- 11.2.4.1. Overview
- 11.2.4.2. Products & services
- 11.2.4.3. SWOT Analysis
- 11.2.4.4. Recent Developments
- 11.2.4.5. Strategies
- 11.2.4.6. Financials (Based on Availability)
- 11.2.5. QIAGEN
- 11.2.5.1. Overview
- 11.2.5.2. Products & services
- 11.2.5.3. SWOT Analysis
- 11.2.5.4. Recent Developments
- 11.2.5.5. Strategies
- 11.2.5.6. Financials (Based on Availability)
- 11.2.6. PerkinElmer Inc.
- 11.2.6.1. Overview
- 11.2.6.2. Products & services
- 11.2.6.3. SWOT Analysis
- 11.2.6.4. Recent Developments
- 11.2.6.5. Strategies
- 11.2.6.6. Financials (Based on Availability)
- 11.2.7. Azenta US, Inc,
- 11.2.7.1. Overview
- 11.2.7.2. Products & services
- 11.2.7.3. SWOT Analysis
- 11.2.7.4. Recent Developments
- 11.2.7.5. Strategies
- 11.2.7.6. Financials (Based on Availability)
- 11.2.8. BGI Genomics
- 11.2.8.1. Overview
- 11.2.8.2. Products & services
- 11.2.8.3. SWOT Analysis
- 11.2.8.4. Recent Developments
- 11.2.8.5. Strategies
- 11.2.8.6. Financials (Based on Availability)
- 11.2.1. Illumina, Inc.
List of Tables
- Table 1: Global DNA Sequencing Market Revenue (USD billion) Forecast, by Products & Services, 2021-2034
- Table 2: Global DNA Sequencing Market Revenue (USD billion) Forecast, by Products, 2021-2034
- Table 3: Global DNA Sequencing Market Revenue (USD billion) Forecast, by Technique 2021-2034
- Table 4: Global DNA Sequencing Market Revenue (USD billion) Forecast, by Type, 2021-2034
- Table 5: Global DNA Sequencing Market Revenue (USD billion) Forecast, by Application, 2021-2034
- Table 6: Global DNA Sequencing Market Revenue (USD billion) Forecast, by End-user 2021-2034
- Table 7: Global DNA Sequencing Market Revenue (USD billion) Forecast, by Region 2021-2034
- Table 8: North America DNA Sequencing Market Revenue (USD billion) Forecast, by Products & Services, 2021-2034
- Table 9: North America DNA Sequencing Market Revenue (USD billion) Forecast, by Product, 2021-2034
- Table 10: North America DNA Sequencing Market Revenue (USD billion) Forecast, by Technique, 2021-2034
- Table 11: North America DNA Sequencing Market Revenue (USD billion) Forecast, by Type, 2021-2034
- Table 12: North America DNA Sequencing Market Revenue (USD billion) Forecast, by Application, 2021-2034
- Table 13: North America DNA Sequencing Market Revenue (USD billion) Forecast, by End-user, 2021-2034
- Table 14: North America DNA Sequencing Market Revenue (USD billion) Forecast, by Country, 2021-2034
- Table 15: Europe DNA Sequencing Market Revenue (USD billion) Forecast, by Products & Services, 2021-2034
- Table 16: Europe DNA Sequencing Market Revenue (USD billion) Forecast, by Products, 2021-2034
- Table 17: Europe DNA Sequencing Market Revenue (USD billion) Forecast, by Technique, 2021-2034
- Table 18: Europe DNA Sequencing Market Revenue (USD billion) Forecast, by Type, 2021-2034
- Table 19: Europe DNA Sequencing Market Revenue (USD billion) Forecast, by Application, 2021-2034
- Table 20: Europe DNA Sequencing Market Revenue (USD billion) Forecast, by End-user, 2021-2034
- Table 21: Europe DNA Sequencing Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2021-2034
- Table 22: Asia Pacific DNA Sequencing Market Revenue (USD billion) Forecast, by Products & Services, 2021-2034
- Table 23: Asia Pacific DNA Sequencing Market Revenue (USD billion) Forecast, by Products, 2021-2034
- Table 24: Asia Pacific DNA Sequencing Market Revenue (USD billion) Forecast, by Technique, 2021-2034
- Table 25: Asia Pacific DNA Sequencing Market Revenue (USD billion) Forecast, by Type, 2021-2034
- Table 26: Asia Pacific DNA Sequencing Market Revenue (USD billion) Forecast, by Application, 2021-2034
- Table 27: Asia Pacific DNA Sequencing Market Revenue (USD billion) Forecast, by End-user, 2021-2034
- Table 28: Asia Pacific DNA Sequencing Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2021-2034
- Table 29: Latin America DNA Sequencing Market Revenue (USD billion) Forecast, by Products & Services, 2021-2034
- Table 30: Latin America DNA Sequencing Market Revenue (USD billion) Forecast, by Products, 2021-2034
- Table 31: Latin America DNA Sequencing Market Revenue (USD billion) Forecast, by Technique, 2021-2034
- Table 32: Latin America DNA Sequencing Market Revenue (USD billion) Forecast, by Type, 2021-2034
- Table 33: Latin America DNA Sequencing Market Revenue (USD billion) Forecast, by Application, 2021-2034
- Table 34: Latin America DNA Sequencing Market Revenue (USD billion) Forecast, by End-user, 2021-2034
- Table 35: Latin America DNA Sequencing Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2021-2034
- Table 36: Middle East & Africa DNA Sequencing Market Revenue (USD billion) Forecast, by Products & Services, 2021-2034
- Table 37: Middle East & Africa DNA Sequencing Market Revenue (USD billion) Forecast, by Products, 2021-2034
- Table 38: Middle East & Africa DNA Sequencing Market Revenue (USD billion) Forecast, by Technique, 2021-2034
- Table 39: Middle East & Africa DNA Sequencing Market Revenue (USD billion) Forecast, by Type, 2021-2034
- Table 40: Middle East & Africa DNA Sequencing Market Revenue (USD billion) Forecast, by Application, 2021-2034
- Table 41: Middle East & Africa DNA Sequencing Market Revenue (USD billion) Forecast, by End-user, 2021-2034
- Table 42: Middle East & Africa DNA Sequencing Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2021-2034
List of Figures
- Figure 1: Global DNA Sequencing Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
- Figure 2: Global DNA Sequencing Market Value Share (%), by Products & Services, 2025 & 2034
- Figure 3: Global DNA Sequencing Market Value Share (%), by Technique, 2025 & 2034
- Figure 4: Global DNA Sequencing Market Value Share (%), by Type, 2025 & 2034
- Figure 5: Global DNA Sequencing Market Value Share (%), by Application, 2025 & 2034
- Figure 6: Global DNA Sequencing Market Value Share (%), by End-user, 2025 & 2034
- Figure 7: Global DNA Sequencing Market Value (USD billion), by Region, 2025 & 2034
- Figure 8: North America DNA Sequencing Market Value Share (%), by Products & Services, 2025 & 2034
- Figure 9: North America DNA Sequencing Market Value Share (%), by Products & Services, 2025
- Figure 10: North America DNA Sequencing Market Value Share (%), by Technique, 2025 & 2034
- Figure 11: North America DNA Sequencing Market Value Share (%), by Technique, 2025
- Figure 12: North America DNA Sequencing Market Value Share (%), by Type, 2025 & 2034
- Figure 13: North America DNA Sequencing Market Value Share (%), by Type, 2025
- Figure 14: North America DNA Sequencing Market Value Share (%), by Application, 2025 & 2034
- Figure 15: North America DNA Sequencing Market Value Share (%), by Application, 2025
- Figure 16: North America DNA Sequencing Market Value Share (%), by End-user, 2025 & 2034
- Figure 17: North America DNA Sequencing Market Value Share (%), by End-user, 2025
- Figure 18: North America DNA Sequencing Market Value (USD billion), By Country, 2025 & 2034
- Figure 19: North America DNA Sequencing Market Value Share (%), By Country, 2025
- Figure 20: Europe DNA Sequencing Market Value Share (%), by Products & Services, 2025 & 2034
- Figure 21: Europe DNA Sequencing Market Value Share (%), by Products & Services, 2025
- Figure 22: Europe DNA Sequencing Market Value Share (%), by Technique, 2025 & 2034
- Figure 23: Europe DNA Sequencing Market Value Share (%), by Technique, 2025
- Figure 24: Europe DNA Sequencing Market Value Share (%), by Type, 2025 & 2034
- Figure 25: Europe DNA Sequencing Market Value Share (%), by Type, 2025
- Figure 26: Europe DNA Sequencing Market Value Share (%), by Application, 2025 & 2034
- Figure 27: Europe DNA Sequencing Market Value Share (%), by Application, 2025
- Figure 28: Europe DNA Sequencing Market Value Share (%), by End-user, 2025 & 2034
- Figure 29: Europe DNA Sequencing Market Value Share (%), by End-user, 2025
- Figure 30: Europe DNA Sequencing Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
- Figure 31: Europe DNA Sequencing Market Value Share (%), By Country/ Sub-region, 2025
- Figure 32: Asia Pacific DNA Sequencing Market Value Share (%), by Products & Services, 2025 & 2034
- Figure 33: Asia Pacific DNA Sequencing Market Value Share (%), by Products & Services, 2025
- Figure 34: Asia Pacific DNA Sequencing Market Value Share (%), by Technique, 2025 & 2034
- Figure 35: Asia Pacific DNA Sequencing Market Value Share (%), by Technique, 2025
- Figure 36: Asia Pacific DNA Sequencing Market Value Share (%), by Type, 2025 & 2034
- Figure 37: Asia Pacific DNA Sequencing Market Value Share (%), by Type, 2025
- Figure 38: Asia Pacific DNA Sequencing Market Value Share (%), by Application, 2025 & 2034
- Figure 39: Asia Pacific DNA Sequencing Market Value Share (%), by Application, 2025
- Figure 40: Asia Pacific DNA Sequencing Market Value Share (%), by End-user, 2025 & 2034
- Figure 41: Asia Pacific DNA Sequencing Market Value Share (%), by End-user, 2025
- Figure 42: Asia Pacific DNA Sequencing Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
- Figure 43: Asia Pacific DNA Sequencing Market Value Share (%), By Country/ Sub-region, 2025
- Figure 44: Latin America DNA Sequencing Market Value Share (%), by Products & Services, 2025 & 2034
- Figure 45: Latin America DNA Sequencing Market Value Share (%), by Products & Services, 2025
- Figure 46: Latin America DNA Sequencing Market Value Share (%), by Technique, 2025 & 2034
- Figure 47: Latin America DNA Sequencing Market Value Share (%), by Technique, 2025
- Figure 48: Latin America DNA Sequencing Market Value Share (%), by Type, 2025 & 2034
- Figure 49: Latin America DNA Sequencing Market Value Share (%), by Type, 2025
- Figure 50: Latin America DNA Sequencing Market Value Share (%), by Application, 2025 & 2034
- Figure 51: Latin America DNA Sequencing Market Value Share (%), by Application, 2025
- Figure 52: Latin America DNA Sequencing Market Value Share (%), by End-user, 2025 & 2034
- Figure 53: Latin America DNA Sequencing Market Value Share (%), by End-user, 2025
- Figure 54: Latin America DNA Sequencing Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
- Figure 55: Latin America DNA Sequencing Market Value Share (%), By Country/ Sub-region, 2025
- Figure 56: Middle East & Africa DNA Sequencing Market Value Share (%), by Products & Services, 2025 & 2034
- Figure 57: Middle East & Africa DNA Sequencing Market Value Share (%), by Products & Services, 2025
- Figure 58: Middle East & Africa DNA Sequencing Market Value Share (%), by Technique, 2025 & 2034
- Figure 59: Middle East & Africa DNA Sequencing Market Value Share (%), by Technique, 2025
- Figure 60: Middle East & Africa DNA Sequencing Market Value Share (%), by Type, 2025 & 2034
- Figure 61: Middle East & Africa DNA Sequencing Market Value Share (%), by Type, 2025
- Figure 62: Middle East & Africa DNA Sequencing Market Value Share (%), by Application, 2025 & 2034
- Figure 63: Middle East & Africa DNA Sequencing Market Value Share (%), by Application, 2025
- Figure 64: Middle East & Africa DNA Sequencing Market Value Share (%), by End-user, 2025 & 2034
- Figure 65: Middle East & Africa DNA Sequencing Market Value Share (%), by End-user, 2025
- Figure 66: Middle East & Africa DNA Sequencing Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
- Figure 67: Middle East & Africa DNA Sequencing Market Value Share (%), By Country/ Sub-region, 2025
- Figure 68: Global DNA Sequencing Market Share (%), By Company, 2025
